Comprehensive Financial Consultants Institutional’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.54M Buy
22,004
+865
+4% +$186K 1.46% 15
2026
Q1
$4.6M Sell
21,139
-48
-0.2% -$10.6K 1.37% 20
2025
Q4
$4.84M Sell
21,187
-1,614
-7% -$368K 1.46% 15
2025
Q3
$5.28M Buy
22,801
+4,144
+22% +$844K 1.64% 12
2025
Q2
$3.46M Buy
18,657
+17,365
+1,344% +$3.23M 1.14% 27
2025
Q1
$271K Buy
1,292
+1
+0.1% +$194 0.1% 150
2024
Q4
$229K Buy
1,291
+2
+0.2% +$368 0.08% 160
2024
Q3
$255K Buy
1,289
+2
+0.2% +$373 0.09% 151
2024
Q2
$221K Hold
1,287
0.09% 152
2024
Q1
$234K Buy
+1,287
New +$222K 0.1% 144
2023
Q2
Sell
-1,294
Closed -$206K 163
2023
Q1
$206K Buy
+1,294
New +$198K 0.12% 158
2022
Q1
Sell
-1,289
Closed -$192K 157
2021
Q4
$192K Buy
+1,289
New +$152K 0.12% 161

Other funds holding ABBV

Comprehensive Financial Consultants Institutional's ABBV Position: Q2 2026 in Review

Comprehensive Financial Consultants Institutional increased its AbbVie (ABBV) stake by 4.1% in Q2 2026, buying an estimated $186K and bringing the position to 22,004 shares worth $5.54M. The position accounts for 1.46% of the portfolio, ranked #15.

Comprehensive Financial Consultants Institutional first reported a position in ABBV in Q4 2021 and has held it in 12 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Comprehensive Financial Consultants Institutional held 22,004 shares of AbbVie worth $5.54M as of Q2 2026.
  • Comprehensive Financial Consultants Institutional bought 865 AbbVie shares in Q2 2026, an estimated $186K.
  • AbbVie made up 1.46% of Comprehensive Financial Consultants Institutional's portfolio in Q2 2026, its #15 holding.
  • Comprehensive Financial Consultants Institutional first reported a position in AbbVie in Q4 2021 and has held it in 12 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Comprehensive Financial Consultants Institutional's 13F filing for Q2 2026, filed 15 Jul 2026.